The authors wish to make the following corrections to this paper \[[@B1-pharmaceutics-12-00514]\]:

The version of [Figure 3](#pharmaceutics-12-00514-f003){ref-type="fig"}a that was uploaded with the manuscript was based on a calculation error, whereas the publication text referred to the correct version of [Figure 3](#pharmaceutics-12-00514-f003){ref-type="fig"}a. After the publication of this work, we noted the mistake and issued an erratum on the *y*-axis. [Figure 3](#pharmaceutics-12-00514-f003){ref-type="fig"}a has now been corrected in this erratum.

The authors would like to apologize for any inconvenience caused to the readers by these changes.

![(**a**) Transendothelial electrical resistance (TEER, expressed as Ω × cm^2^) and (**b**) endothelial Pe for sodium fluorescein (NaFl) and FITC-dextran (Pe, expressed in cm/s) of the blood--brain barrier models built from mouse primary brain endothelial cells (BMEC, blue) and from mouse brain endothelial cell line (bEnd.3, red) at day 7. All data are presented as means ± SD (*n* = 12 for TEER, *n* = 4 for Pe). Statistical analysis: unpaired t test with Welch's correction (ns: *p* ≥ 0.0332, \*\*\*\* *p* \< 0.0001, ND- not detected).](pharmaceutics-12-00514-g001){#pharmaceutics-12-00514-f003}
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